Breakthrough Infections in Lupus Patients Down With COVID Booster
Sixty-four percent of those with breakthrough COVID-19 had received booster compared with 82 percent of those without breakthrough infection
NIH Trial Underway for Universal Flu Vaccine
Phase 1 trial testing both intranasal and intramuscular administration
Biden Administration May Back Second Booster Shots for All Adults
Expanding eligibility requirements for a fourth dose of the vaccine would require regulatory approval
Treatment for Hep C Up Among People Who Inject Drugs
Among PWID with chronic HCV infection, proportion with detectable HCV RNA decreased from 100 percent in 2006 to 48 percent in 2019
Infant Hospitalization for COVID-19 Reduced With Maternal Vaccination
Effectiveness of maternal vaccination against COVID-19 hospitalization in infants 80 percent during delta, 38 percent during omicron
New Omicron Subvariant Spreading in India, United States
New mutation -- BA.2.75 -- has been detected in 10 other countries, including Australia, Germany, the United Kingdom, and Canada
Low Risk Seen for Health Care-Linked Monkeypox Transmission
From 2000 to 2022, only one case of health care-associated transmission described, following high-risk exposure to contaminated bedding
Adverse Reactions to BNT162b2 Mild, Moderate for 5- to 11-Year-Olds
Based on data from three U.S. safety monitoring systems, adverse events were mild-to-moderate, and myocarditis occurred rarely
COVID-19 Among Top 5 Causes of Death in the U.S.
As pandemic wears on, ranking of COVID-19 as a leading cause of death has increased among younger age groups
Laboratory Response Network Facilitates Rapid ID of Monkeypox
CDC has confirmed non-variola Orthopoxvirus-positive specimens from 159 patients to be monkeypox
